Vicki L. Keedy, M.D.

Associate Professor
Faculty Appointments
Associate Professor of Medicine
M.S.C.I., Clinical Investigation , Vanderbilt University, Nashville, TennesseeM.D., MEDICINE, University of Cincinnati, Cincinnati, OhioB.S., Indiana University, Bloomington, Indiana
Office Address
2220 Pierce Ave 777 PRB
TN 6307
Grilley-Olson JE, Keedy VL, Sandler A, Moore DT, Socinski MA, Stinchcombe TE. A randomized phase II study of carboplatin with weekly or every-3-week nanoparticle albumin-bound paclitaxel (abraxane) in patients with extensive-stage small cell lung cancer. Oncologist [print-electronic]. 2015 Feb; 20(2): 105-6. PMID: 25616430, PMCID: PMC4319632, PII: theoncologist.2014-0327, DOI: 10.1634/theoncologist.2014-0327, ISSN: 1549-490X.

Wu H, Infante JR, Keedy VL, Jones SF, Chan E, Bendell JC, Lee W, Kirschbrown WP, Zamboni BA, Ikeda S, Kodaira H, Rothenberg ML, Burris HA, Zamboni WC. Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors. Int J Nanomedicine. 2015; 10: 1201-9. PMID: 25709442, PMCID: PMC4334335, PII: ijn-10-1201, DOI: 10.2147/IJN.S62911, ISSN: 1178-2013.

Johnson DB, Dahlman KH, Knol J, Gilbert J, Puzanov I, Means-Powell J, Balko JM, Lovly CM, Murphy BA, Goff LW, Abramson VG, Crispens MA, Mayer IA, Berlin JD, Horn L, Keedy VL, Reddy NM, Arteaga CL, Sosman JA, Pao W. Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel. Oncologist [print-electronic]. 2014 Jun; 19(6): 616-22. PMID: 24797823, PMCID: PMC4041676, PII: theoncologist.2014-0011, DOI: 10.1634/theoncologist.2014-0011, ISSN: 1549-490X.

Lammers PE, Shyr Y, Li CI, Hutchison AS, Sandler A, Carbone DP, Johnson DH, Keedy VL, Horn L. Phase II study of bendamustine in relapsed chemotherapy sensitive or resistant small-cell lung cancer. J Thorac Oncol. 2014 Apr; 9(4): 559-62. PMID: 24736081, PMCID: PMC3990869, PII: 01243894-201404000-00024, DOI: 10.1097/JTO.0000000000000079, ISSN: 1556-1380.

Stevens PL, Johnson DB, Thompson MA, Keedy VL, Frangoul HA, Snyder KM. Adult neuroblastoma complicated by increased intracranial pressure: a case report and review of the literature. Case Rep Oncol Med [print-electronic]. 2014; 2014: 341980. PMID: 25328733, PMCID: PMC4190830, DOI: 10.1155/2014/341980, ISSN: 2090-6706.

Cate F, Bridge JA, Crispens MA, Keedy VL, Troutman A, Coffin CM, Fadare O. Composite uterine neoplasm with embryonal rhabdomyosarcoma and primitive neuroectodermal tumor components: rhabdomyosarcoma with divergent differentiation, variant of primitive neuroectodermal tumor, or unique entity?. Hum. Pathol [print-electronic]. 2013 Apr; 44(4): 656-63. PMID: 23266445, PII: S0046-8177(12)00336-X, DOI: 10.1016/j.humpath.2012.09.008, ISSN: 1532-8392.

Abramson RG, Abramson VG, Chan E, Horn L, Keedy VL, Pao W, Sosman JA. Complications of targeted drug therapies for solid malignancies: manifestations and mechanisms. AJR Am J Roentgenol. 2013 Mar; 200(3): 475-83. PMID: 23436834, PMCID: PMC3652983, PII: 200/3/475, DOI: 10.2214/AJR.12.9049, ISSN: 1546-3141.

Horn L, Keedy VL, Campbell N, Garcia G, Hayes A, Spencer B, Carbone DP, Sandler A, Johnson DH. Identifying barriers associated with enrollment of patients with lung cancer into clinical trials. Clin Lung Cancer [print-electronic]. 2013 Jan; 14(1): 14-8. PMID: 22591607, PII: S1525-7304(12)00075-7, DOI: 10.1016/j.cllc.2012.03.008, ISSN: 1938-0690.

Mignemi NA, Itani DM, Fasig JH, Keedy VL, Hande KR, Whited BW, Homlar KC, Correa H, Coffin CM, Black JO, Yi Y, Halpern JL, Holt GE, Schwartz HS, Schoenecker JG, Cates JM. Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-ß, COX2 and sex steroid receptors. Cancer Sci [print-electronic]. 2012 Dec; 103(12): 2173-80. PMID: 23035734, PMCID: PMC4278584, DOI: 10.1111/cas.12037, ISSN: 1349-7006.

Kallen ME, Sanders ME, Gonzalez AL, Black JO, Keedy VL, Hande KR, Homlar KC, Halpern JL, Holt GE, Schwartz HS, Coffin CM, Cates JM. Nuclear p63 expression in osteoblastic tumors. Tumour Biol [print-electronic]. 2012 Oct; 33(5): 1639-44. PMID: 22623071, DOI: 10.1007/s13277-012-0419-y, ISSN: 1423-0380.

Cates JM, Black JO, Itani DM, Fasig JH, Keedy VL, Hande KR, Whited BW, Homlar KC, Halpern JL, Holt GE, Schwartz HS, Coffin CM. Signal transduction pathway analysis in fibromatosis: receptor and nonreceptor tyrosine kinases. Hum. Pathol [print-electronic]. 2012 Oct; 43(10): 1711-8. PMID: 22520949, PMCID: PMC4278590, PII: S0046-8177(11)00530-2, DOI: 10.1016/j.humpath.2011.12.021, ISSN: 1532-8392.

Cates JM, Black J, Wolfe CC, Shinohara ET, Holt GE, Keedy VL, Hande KR, Homlar KC, Halpern JL, Schwartz HS, Troutman A, Coffin CM. Morphologic and immunophenotypic analysis of desmoid-type fibromatosis after radiation therapy. Hum. Pathol [print-electronic]. 2012 Sep; 43(9): 1418-24. PMID: 22404950, PII: S0046-8177(11)00462-X, DOI: 10.1016/j.humpath.2011.11.002, ISSN: 1532-8392.

Keedy VL. Treating metastatic soft-tissue or bone sarcomas - potential role of ridaforolimus. Onco Targets Ther [print-electronic]. 2012; 5: 153-60. PMID: 22942649, PMCID: PMC3428242, PII: ott-5-153, DOI: 10.2147/OTT.S19055, ISSN: 1178-6930.

Keedy VL, Temin S, Somerfield MR, Beasley MB, Johnson DH, McShane LM, Milton DT, Strawn JR, Wakelee HA, Giaccone G. American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy. J. Clin. Oncol [print-electronic]. 2011 May 5/20/2011; 29(15): 2121-7. PMID: 21482992, PII: JCO.2010.31.8923, DOI: 10.1200/JCO.2010.31.8923, ISSN: 1527-7755.

Tatsas AD, Keedy VL, Florell SR, Simpson JF, Coffin CM, Kelley MC, Cates JM. Foamy cell angiosarcoma: a rare and deceptively bland variant of cutaneous angiosarcoma. J. Cutan. Pathol [print-electronic]. 2010 Aug; 37(8): 901-6. PMID: 20175826, PII: CUP1512, DOI: 10.1111/j.1600-0560.2010.01512.x, ISSN: 1600-0560.

Moretti L, Yu DS, Chen H, Carbone DP, Johnson DH, Keedy VL, Putnam JB, Sandler AB, Shyr Y, Lu B. Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy. Oncologist [print-electronic]. 2009 Nov; 14(11): 1106-15. PMID: 19897534, PMCID: PMC3045762, PII: theoncologist.2009-0130, DOI: 10.1634/theoncologist.2009-0130, ISSN: 1549-490X.

Herceg ME, Tsiatis AC, Halpern JL, Holt GE, Schwartz HS, Keedy VL, Cates JM. Cyclooxygenase 2 expression in soft tissue leiomyosarcoma. Anticancer Res. 2009 Aug; 29(8): 2913-7. PMID: 19661295, PII: 29/8/2913, ISSN: 1791-7530.

Keedy VL, Sandler AB. Inhibition of angiogenesis in the treatment of non-small cell lung cancer. Cancer Sci [print-electronic]. 2007 Dec; 98(12): 1825-30. PMID: 17892508, PII: CAS620, DOI: 10.1111/j.1349-7006.2007.00620.x, ISSN: 1349-7006.

Keedy VL, Berlin J. Adjuvant and neoadjuvant approaches to treat surgically resectable pancreatic cancer. Curr Treat Options Oncol. 2006 Sep; 7(5): 381-8. PMID: 16904055, ISSN: 1527-2729.